ciprofloxacin has been researched along with rufloxacin in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (60.00) | 18.2507 |
| 2000's | 4 (40.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bonelli, D; Cecchetti, V; Clementi, M; Clementi, S; Cruciani, G; Filipponi, E; Fravolini, A; Tabarrini, O | 1 |
| Carrupt, PA; Crivori, P; Cruciani, G; Testa, B | 1 |
| Calistri, A; Cecchetti, V; Filipponi, E; Fravolini, A; Gatto, B; Moro, S; Palu', G; Palumbo, M; Parolin, C; Pecere, T; Tabarrini, O | 1 |
| Bach, D; Cesana, M; Hübner, A; Plétan, Y; van Breukelen, G; van den Berg-Segers, A | 1 |
| Chuah, SK; Gollapudi, SV; Harvey, T; Thadepalli, H; Thadepalli, HD | 1 |
| Cecchetti, V; Fravolini, A; Pagella, PG; Tabarrini, O; Wise, R | 1 |
| Choi, EC; Choi, KH; Hong, JS; Kim, SK; Lee, DK; Yoon, SJ | 1 |
| Asuquo, AE; Jin, YF; Piddock, LJ; Ricci, V | 1 |
| Belgrano, E; Buttazzi, L; Ciampalini, S; Lissiani, A; Plaino, F; Raber, M; Savoca, G | 1 |
| Andreeva, I; Rafalsky, V; Rjabkova, E | 1 |
2 review(s) available for ciprofloxacin and rufloxacin
| Article | Year |
|---|---|
Comparison of single preoperative oral rufloxacin versus perioperative ciprofloxacin as prophylactic agents in transurethral surgery.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Antibiotic Prophylaxis; Ciprofloxacin; Female; Fluoroquinolones; Humans; Male; Middle Aged; Prospective Studies; Quinolones; Urethra; Urologic Surgical Procedures | 2000 |
Quinolones for uncomplicated acute cystitis in women.
Topics: Acute Disease; Adult; Anti-Infective Agents, Urinary; Ciprofloxacin; Cystitis; Female; Fluoroquinolones; Humans; Levofloxacin; Norfloxacin; Ofloxacin; Pefloxacin; Quinolones; Randomized Controlled Trials as Topic | 2006 |
2 trial(s) available for ciprofloxacin and rufloxacin
| Article | Year |
|---|---|
Rufloxacin once daily versus ciprofloxacin twice daily in the treatment of patients with acute uncomplicated pyelonephritis.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Ambulatory Care; Anti-Infective Agents; Ciprofloxacin; Double-Blind Method; Drug Administration Schedule; Escherichia coli Infections; Female; Fluoroquinolones; Follow-Up Studies; Humans; Male; Middle Aged; Pyelonephritis; Quinolones; Treatment Outcome | 1995 |
Comparison of single preoperative oral rufloxacin versus perioperative ciprofloxacin as prophylactic agents in transurethral surgery.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Antibiotic Prophylaxis; Ciprofloxacin; Female; Fluoroquinolones; Humans; Male; Middle Aged; Prospective Studies; Quinolones; Urethra; Urologic Surgical Procedures | 2000 |
7 other study(ies) available for ciprofloxacin and rufloxacin
| Article | Year |
|---|---|
Chemometric methodologies in a quantitative structure-activity relationship study: the antibacterial activity of 6-aminoquinolones.
Topics: Aminoquinolines; Anti-Infective Agents; Bacteria; Computer Simulation; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests; Models, Chemical; Molecular Structure; Quinolones; Structure-Activity Relationship | 1997 |
Predicting blood-brain barrier permeation from three-dimensional molecular structure.
Topics: Blood-Brain Barrier; Databases, Factual; Models, Chemical; Molecular Conformation; Multivariate Analysis; Permeability; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
6-Aminoquinolones as new potential anti-HIV agents.
Topics: Animals; Anti-HIV Agents; Cell Line; Chlorocebus aethiops; DNA, Viral; Herpesvirus 1, Human; HIV-1; Piperazines; Quinolones; Reverse Transcriptase Inhibitors; RNA, Viral; Spectrometry, Fluorescence; Structure-Activity Relationship; Vero Cells | 2000 |
In vivo effects of rufloxacin and ciprofloxacin on T-cell subsets and tumor necrosis factor production in mice infected with Bacteroides fragilis.
Topics: Animals; Anti-Infective Agents; Bacteroides fragilis; Bacteroides Infections; CD4-CD8 Ratio; Cell Division; Ciprofloxacin; Female; Fluoroquinolones; Mice; Mice, Inbred C3H; Organ Size; Quinolones; Spleen; T-Lymphocyte Subsets; T-Lymphocytes; Tumor Necrosis Factor-alpha | 1993 |
In vitro activity of MF 5137, a new potent 6-aminoquinolone.
Topics: 4-Quinolones; Anti-Infective Agents; Bacteria; Ciprofloxacin; Culture Media; Fluoroquinolones; Isoquinolines; Microbial Sensitivity Tests; Quinolones | 1995 |
In-vitro and in-vivo activities of DW-116, a new fluoroquinolone.
Topics: Animals; Anti-Infective Agents; Bacterial Infections; Ciprofloxacin; Dose-Response Relationship, Drug; Enterococcus faecalis; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Male; Methicillin Resistance; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Ofloxacin; Piperazines; Pseudomonas aeruginosa; Quinolones; Staphylococcus aureus | 1997 |
Quinolone accumulation by Pseudomonas aeruginosa, Staphylococcus aureus and Escherichia coli.
Topics: Anti-Infective Agents; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Ciprofloxacin; Diffusion; Dose-Response Relationship, Drug; Enoxacin; Enrofloxacin; Escherichia coli; Fluorescence; Fluoroquinolones; Hydrogen-Ion Concentration; Microbial Sensitivity Tests; Nalidixic Acid; Pseudomonas aeruginosa; Quinolones; Spheroplasts; Staphylococcus aureus; Temperature | 1999 |